Holen Sie sich die Stockscreener-App
20.46
6.10%
-1.33
Handel nachbörslich:
20.46
Schlusskurs vom Vortag:
$21.79
Offen:
$21.81
24-Stunden-Volumen:
319.58K
Relative Volume:
1.12
Marktkapitalisierung:
$1.48B
Einnahmen:
$26.98M
Nettoeinkommen (Verlust:
$-180.66M
KGV:
-4.3718
EPS:
-4.68
Netto-Cashflow:
$-63.56M
1W Leistung:
-15.87%
1M Leistung:
-24.31%
6M Leistung:
-4.21%
1J Leistung:
+47.73%
1-Tages-Spanne:
$20.46
$22.18
1-Wochen-Bereich:
$20.46
$24.26
52-Wochen-Spanne:
$13.07
$28.67
Bicycle Therapeutics Plc Adr Stock (BCYC) Company Profile
Firmenname
Bicycle Therapeutics Plc Adr
Sektor
Branche
Telefon
011441223261503
Adresse
BLOCKS A & B, PORTWAY BUILDING, CAMBRIDGE
Vergleichen Sie BCYC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| BCYC | 20.46 | 1.48B | 26.98M | -180.66M | -63.56M | -4.68 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Bicycle Therapeutics Plc Adr Stock (BCYC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-11 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2022-08-31 | Eingeleitet | Cowen | Outperform |
| 2022-07-28 | Eingeleitet | Barclays | Overweight |
| 2022-07-06 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-04-13 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-04-07 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2022-02-14 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | SVB Leerink | Outperform |
| 2021-12-09 | Eingeleitet | Needham | Buy |
| 2021-09-30 | Eingeleitet | B. Riley Securities | Buy |
| 2021-04-20 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-10-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-06-12 | Eingeleitet | Oppenheimer | Outperform |
| 2020-04-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-11-14 | Eingeleitet | ROTH Capital | Buy |
| 2019-09-11 | Hochstufung | Goldman | Neutral → Buy |
| 2019-06-17 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-06-17 | Eingeleitet | Goldman | Neutral |
| 2019-06-17 | Eingeleitet | Jefferies | Buy |
| 2019-06-17 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Bicycle Therapeutics Plc Adr Aktie (BCYC) Neueste Nachrichten
Bicycle Therapeutics' SWOT analysis: innovative platform fuels stock's potential - Investing.com India
Bicycle Therapeutics' chief accounting officer sells shares worth $157,113 - Investing.com
Bicycle Therapeutics' SWOT analysis: stock's potential rides on innovative platform - Investing.com India
Bicycle Therapeutics spotlights cancer treatment targets - Investing.com
Bicycle Therapeutics (BCYC) Soars 5.7%: Is Further Upside Left in the Stock? - MSN
A company insider recently sold 3,212 shares of Bicycle Therapeutics Plc ADR [BCYC]. Should You also Consider to Sale? – Knox Daily - Knox Daily
BCYC’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle
Keeping an Eye on Bicycle Therapeutics Plc ADR (BCYC) After Insider Trading Activity - Knox Daily
Bicycle Therapeutics Plc ADR (BCYC)’s stock price range in the last year - US Post News
Bicycle therapeutics executive sells shares worth over $21k - Investing.com India
Bicycle therapeutics executive sells shares to cover tax obligations - Investing.com India
Bicycle therapeutics COO sells shares worth over $21k - Investing.com India
Bicycle therapeutics CEO sells shares worth over $71k - Investing.com
Bicycle therapeutics CTO sells shares worth over $21k - Investing.com
Bicycle therapeutics executive sells shares worth over $5,000 - Investing.com
CHIEF PROD & SUPPLY CHAIN OFF Hannay Michael Charles Ferguso sale 246 shares of Bicycle Therapeutics Plc ADR [BCYC] – Knox Daily - Knox Daily
Bicycle Therapeutics Plc ADR (BCYC)’s stock chart: A technical perspective - US Post News
Market Update: Bicycle Therapeutics Plc ADR (BCYC) Sees Negative Movement, Closing at 22.56 - The Dwinnex
Wall Street SWOT: Bicycle Therapeutics stock rides high on cancer drug promise - Investing.com
A company insider recently sold 246 shares of Bicycle Therapeutics Plc ADR [BCYC]. Should You Sale? - Knox Daily
Nothing is Better Than Bicycle Therapeutics Plc ADR (BCYC) stock at the moment - SETE News
RBC Capital Mkts initates Bicycle Therapeutics Plc ADR (BCYC) stock to an Outperform - Knox Daily
Metric Analysis: Bicycle Therapeutics Plc ADR (BCYC)’s Key Ratios in the Limelight - The Dwinnex
Bicycle Therapeutics Plc ADR: A Year of Highs, Lows, and Market Resilience - The InvestChronicle
Are Bicycle Therapeutics Plc ADR (BCYC) shares a good deal now? - US Post News
Hain Celestial Group Inc [HAIN] Investment Guide: What You Need to Know - Knox Daily
Bicycle Therapeutics stock maintains Buy rating post-ESMO data By Investing.com - Investing.com UK
Bicycle Therapeutics Plc ADR [BCYC] Shares Fall -0.26 % on Wednesday - Knox Daily
A stock that deserves closer examination: Bicycle Therapeutics Plc ADR (BCYC) - US Post News
Bicycle Therapeutics Plc ADR (BCYC) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
Aqua Metals Inc [AQMS] Shares Fall Approximately -81.89% Over the Year - Knox Daily
Taking a look at what insiders are doing to gauge the Interface Inc. [TILE] - Knox Daily
Sleep Number Corp [SNBR] Director makes an insider purchase of 43,000 shares worth 0.53 million. - Knox Daily
Top investors say Bicycle Therapeutics Plc ADR (BCYC) ticks everything they need - SETE News
Bicycle Therapeutics (BCYC) Moves to Buy: Rationale Behind the Upgrade - MSN
An Analysis of Bicycle Therapeutics Plc ADR (BCYC)’s Potential Price Growth - Knox Daily
CDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q2 2024 - MSN
What Makes Bicycle Therapeutics (BCYC) a New Buy Stock - Yahoo Finance
Wall Street Analysts See an 88.94% Upside in Bicycle Therapeutics (BCYC): Can the Stock Really Move This High? - Yahoo Finance
B. Riley Securities’s latest rating for BCYC stock - Knox Daily
Bicycle Therapeutics Plc ADR (BCYC) may enjoy gains as insiders got busy in the recent days - Knox Daily
Bicycle Therapeutics Plc ADR’s latest rating changes from various analysts - Knox Daily
Bicycle Therapeutics Plc ADR [BCYC] Investment Appeal on the Rise – Knox Daily - Knox Daily
Is it a good time to sell Wendy's Co [WEN] shares after an insider sold 21000 shares? – Knox Daily - Knox Daily
Strength Seen in Bicycle Therapeutics PLC Sponsored ADR (BCYC): Can Its 5.9% Jump Turn into More Strength? - Yahoo Movies UK
Bicycle (BCYC) to Begin Pivotal Bladder Cancer Study, Stock Up - Yahoo News Malaysia
Bicycle Therapeutics PLC Sponsored ADR (BCYC) Soars 19.3%: Is Further Upside Left in the Stock? - Yahoo Sport Australia
Are Medical Stocks Lagging Bicycle Therapeutics (BCYC) This Year? - Yahoo Finance
Investing in Bicycle Therapeutics Plc ADR (BCYC) Is Getting More Attractive – Knox Daily - Knox Daily
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio - Zacks Investment Research
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio - Zacks Investment Research
Finanzdaten der Bicycle Therapeutics Plc Adr-Aktie (BCYC)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):